Literature DB >> 24138341

Treating pain in addicted patients: recommendations from an expert panel.

Martin Cheatle1, Dominique Comer, Martha Wunsch, Alexis Skoufalos, Yeshwant Reddy.   

Abstract

Clinicians may face pragmatic, ethical, and legal issues when treating addicted patients. Equal pressures exist for clinicians to always address the health care needs of these patients in addition to their addiction. Although controversial, mainly because of the lack of evidence regarding their long-term efficacy, the use of opioids for the treatment of chronic pain management is widespread. Their use for pain management in the addicted population can present even more challenges, especially when evaluating the likelihood of drug-seeking behavior. As the misuse and abuse of opioids continues to burgeon, clinicians must be particularly vigilant when prescribing chronic opioid therapy. The purpose of this article is to summarize recommendations from a recent meeting of experts convened to recommend how primary care physicians should approach treatment of chronic pain for addicted patients when an addiction specialist is not available for a referral. As there is a significant gap in guidelines and recommendations in this specific area of care, this article serves to create a foundation for expanding chronic pain guidelines in the area of treating the addicted population. This summary is designed to be a practical how-to guide for primary care physicians, discussing risk assessment, patient stratification, and recommended therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24138341      PMCID: PMC3996998          DOI: 10.1089/pop.2013.0041

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  59 in total

Review 1.  Informed consent in opioid therapy: a potential obligation and opportunity.

Authors:  Martin D Cheatle; Seddon R Savage
Journal:  J Pain Symptom Manage       Date:  2012-03-21       Impact factor: 3.612

2.  Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria.

Authors:  Joseph A Boscarino; Margaret R Rukstalis; Stuart N Hoffman; John J Han; Porat M Erlich; Stephen Ross; Glenn S Gerhard; Walter F Stewart
Journal:  J Addict Dis       Date:  2011 Jul-Sep

3.  Drug poisoning deaths in the United States, 1980-2008.

Authors:  Margaret Warner; Li Hui Chen; Diane M Makuc; Robert N Anderson; Arialdi M Miniño
Journal:  NCHS Data Brief       Date:  2011-12

Review 4.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Authors:  Søren H Sindrup; Troels S Jensen
Journal:  Pain       Date:  1999-12       Impact factor: 6.961

Review 5.  Recommendations and guidelines regarding the preferred research protocol for investigating the impact of an optimal healing environment on patients with substance abuse.

Authors:  Kathleen M Wesa; Patricia Culliton
Journal:  J Altern Complement Med       Date:  2004       Impact factor: 2.579

Review 6.  Do minimally invasive procedures have a place in the treatment of chronic low back pain?

Authors:  Alex Cahana; Philippe Mavrocordatos; Jos W M Geurts; Gerbrand J Groen
Journal:  Expert Rev Neurother       Date:  2004-05       Impact factor: 4.618

7.  The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers.

Authors:  Patricia L Dobkin; Civita Mirella De; Antonios Paraherakis; Kathryn Gill
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

8.  Development and validation of the Current Opioid Misuse Measure.

Authors:  Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison
Journal:  Pain       Date:  2007-05-09       Impact factor: 6.961

9.  A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.

Authors:  Lesley M Arnold; I Jon Russell; E W Diri; W Rachel Duan; James P Young; Uma Sharma; Susan A Martin; Jeannette A Barrett; George Haig
Journal:  J Pain       Date:  2008-06-03       Impact factor: 5.820

10.  The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.

Authors:  Philip J Mease; Daniel J Clauw; R Michael Gendreau; Srinivas G Rao; Jay Kranzler; Wei Chen; Robert H Palmer
Journal:  J Rheumatol       Date:  2009-02       Impact factor: 4.666

View more
  4 in total

Review 1.  Treatment Strategies for the Opioid-Dependent Patient.

Authors:  Shweta Teckchandani; Meredith Barad
Journal:  Curr Pain Headache Rep       Date:  2017-09-20

2.  Positive Toxicology Results Are Not Associated with Emergency Physicians' Opioid Prescribing Behavior.

Authors:  Jonathan B Lee; Ghadi Ghanem; Soheil Saadat; Justin Yanuck; Brent Yeung; Bharath Chakravarthy; Ariana Nelson; Shalini Shah
Journal:  West J Emerg Med       Date:  2021-08-30

Review 3.  Framework for opioid stigma in cancer pain.

Authors:  Hailey W Bulls; Edward Chu; Burel R Goodin; Jane M Liebschutz; Antoinette Wozniak; Yael Schenker; Jessica S Merlin
Journal:  Pain       Date:  2022-02-01       Impact factor: 7.926

4.  Opioid Use Disorder and Assessment of Patient Interactions Among Family Medicine Residents, Medical Students, and Physician Assistant Students.

Authors:  John G Spangler; Catherine N Shull; Carol A Hildebrandt; Keli Beck Jones; Andrew L Brewer; Mark P Knudson; Gail S Marion; Julienne K Kirk
Journal:  MedEdPORTAL       Date:  2020-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.